TY - PAT
T1 - Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides.
AU - Binnemans, Koen
AU - Goerller-Walrand, Christiane Anna
AU - Nockemann, Peter
AU - Thijs, Ben.
PY - 2007/12/27
Y1 - 2007/12/27
N2 - Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6% versus 46/336, 13.7%, P
AB - Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6% versus 46/336, 13.7%, P
KW - ionic liq bistrifluoromethylsulfonylimide betaine
M3 - Patent
M1 - WO2007147222A2
PB - Ku Leuven
ER -
